BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14715826)

  • 1. Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells.
    Costa-Santos M; Kater CE; Dias EP; Auchus RJ
    J Clin Endocrinol Metab; 2004 Jan; 89(1):43-8. PubMed ID: 14715826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5'-splice site mutation in the cytochrome P450 steroid 17alpha-hydroxylase gene in 17alpha-hydroxylase deficiency.
    Yamaguchi H; Nakazato M; Miyazato M; Kangawa K; Matsukura S
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1934-8. PubMed ID: 9177409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiency.
    Hwang DY; Hung CC; Riepe FG; Auchus RJ; Kulle AE; Holterhus PM; Chao MC; Kuo MC; Hwang SJ; Chen HC
    PLoS One; 2011; 6(9):e25492. PubMed ID: 21966534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel splicing mutation and 1-bp deletion in the 17alpha-hydroxylase gene of Japanese patients with 17alpha-hydroxylase deficiency.
    Yamaguchi H; Nakazato M; Miyazato M; Toshimori H; Oki S; Shimizu K; Suiko M; Kangawa K; Matsukura S
    Hum Genet; 1998 Jun; 102(6):635-9. PubMed ID: 9703423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel mutation of the CYP17 gene in two unrelated patients with combined 17alpha-hydroxylase/17,20-lyase deficiency: demonstration of absent enzyme activity by expressing the mutant CYP17 gene and by three-dimensional modeling.
    Patocs A; Liko I; Varga I; Gergics P; Boros A; Futo L; Kun I; Bertalan R; Toth S; Pazmany T; Toth M; Szücs N; Horanyi J; Glaz E; Racz K
    J Steroid Biochem Mol Biol; 2005 Nov; 97(3):257-65. PubMed ID: 16176874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seventeen alpha-hydroxylase deficiency with one base pair deletion of the cytochrome P450c17 (CYP17) gene.
    Oshiro C; Takasu N; Wakugami T; Komiya I; Yamada T; Eguchi Y; Takei H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2526-9. PubMed ID: 7629254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
    Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
    Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection.
    Sakai N; Santamarina-Fojo S; Yamashita S; Matsuzawa Y; Brewer HB
    J Lipid Res; 1996 Oct; 37(10):2065-73. PubMed ID: 8906584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique exonic splicing mutation in the CYP17A1 gene as the cause for steroid 17{alpha}-hydroxylase deficiency.
    Qiao J; Han B; Liu BL; Liu W; Wu JJ; Pan CM; Jiang H; Gu T; Jiang BR; Zhu H; Lu YL; Wu WL; Chen MD; Song HD
    Eur J Endocrinol; 2011 Apr; 164(4):627-33. PubMed ID: 21282350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered mRNA expression due to insertion or substitution of thymine at position +3 of two splice-donor sites in the androgen receptor gene.
    Trifiro MA; Lumbroso R; Beitel LK; Vasiliou DM; Bouchard J; Deal C; Van Vliet G; Pinsky L
    Eur J Hum Genet; 1997; 5(1):50-8. PubMed ID: 9156321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare intronic mutation in the splice acceptor site of the CYP17A1 gene in a patient with 17α-hydroxylase/17,20-lyase deficiency.
    Guo X; Wang H; Xiang Y; Ren X; Jiang S
    Gynecol Endocrinol; 2021 Jan; 37(1):97-100. PubMed ID: 32945709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple transcripts of the CYP21 gene are generated by the mutation of the splicing donor site in intron 2 from GT to AT in 21-hydroxylase deficiency.
    Lee HH; Chang SF
    J Endocrinol; 2001 Dec; 171(3):397-402. PubMed ID: 11739005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel compound heterozygous mutation in the CYP17 (P450 17alpha-hydroxylase) gene leading to 17alpha-hydroxylase/17,20-lyase deficiency.
    Hahm JR; Kim DR; Jeong DK; Chung JH; Lee MS; Min YK; Kim KW; Lee MK
    Metabolism; 2003 Apr; 52(4):488-92. PubMed ID: 12701064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease.
    Fujimaru M; Tanaka A; Choeh K; Wakamatsu N; Sakuraba H; Isshiki G
    Hum Genet; 1998 Oct; 103(4):462-9. PubMed ID: 9856491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE; Conney AH; Wei SJ
    Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
    Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
    PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping of five chinese patients with 17alpha-hydroxylase deficiency diagnosed through high-performance liquid chromatography serum adrenal profile: identification of two novel CYP17 mutations.
    Wei JQ; Wei JL; Li WC; Bi YS; Wei FC
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3647-53. PubMed ID: 16822828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new compound heterozygous mutation (W17X, 436 + 5G --> T) in the cytochrome P450c17 gene causes 17 alpha-hydroxylase/17,20-lyase deficiency.
    Suzuki Y; Nagashima T; Nomura Y; Onigata K; Nagashima K; Morikawa A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):199-202. PubMed ID: 9435441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.
    Holla ØL; Nakken S; Mattingsdal M; Ranheim T; Berge KE; Defesche JC; Leren TP
    Mol Genet Metab; 2009 Apr; 96(4):245-52. PubMed ID: 19208450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences.
    Mayer K; Ballhausen W; Leistner W; Rott H
    Biochim Biophys Acta; 2000 Nov; 1502(3):495-507. PubMed ID: 11068191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.